Status:
RECRUITING
Impact of Bruxism in the Outcome of Subgingival Instrumentation for the Management of Stage 2 and Stage 3 Periodontitis.
Lead Sponsor:
Postgraduate Institute of Dental Sciences Rohtak
Conditions:
Periodontitis
Bruxism
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
Bruxism is a multifaceted phenomenon that has been associated with several factors mediated by the central nervous system3. Bruxism is an umbrella term grouping different motor phenomenon. 'Bruxism is...
Detailed Description
AIM : To study the impact of bruxism in the outcome of subgingival instrumentation for the management of Stage 2 and Stage 3 periodontitis. OBJECTIVES: To assess the association of bruxism with peri...
Eligibility Criteria
Inclusion
- TEST GROUP
- Systemically healthy patients
- Patient having stage 2 or stage 3 periodontitis with bruxism Age between 30-50 years
- Minimum 20 teeth present in oral cavity
- CONTROL GROUP
- Systemically healthy patients
- Patient having stage 2 or stage 3 periodontitis without bruxism
- Age between 30-50 years
- Minimum 20 teeth present in oral cavity
Exclusion
- History of systemic disease such as diabetes or autoimmune disease
- History of drugs having the potential impact on periodontal status like phenytoin, cyclosporin, calcium-channel blockers or antidepressant drugs
- Pregnant or lactating females
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT05995431
Start Date
September 1 2023
End Date
November 1 2024
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post Graduate Institute of Dental Sciences
Rohtak, Haryana, India, 124001